Ingersoll Rand Inc. IR SPXR3K
Company Overview
Ingersoll Rand Inc. provides mission-critical air, fluid, clean energy, and medical technologies services and solutions worldwide. It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services a range of air and gas compression and treatment equipment, vacuum and blower products, fluid transfer equipment, loading systems, and power tools and lifting equipment; and other specialized equipment, including aftermarket parts, consumables and services, air treatment equipment, controls, other accessories, and services under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, and other brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for precision dosing, liquid and solid transfer, dispensing, gas compression and sampling, pressure management, flow control, powder handling, and other applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, Ingersoll Rand, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brands. This segment's products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. It sells its products through a network of direct sales representatives and independent distributors. It has a strategic alliance with Garrett Motion. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.
Why Investors Should Care
Revenue has grown at a 13.7% CAGR over the past five years.
Operating margin of 16.9% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $7.65B (+5.7% YoY); net profit $581.40M.
- Trailing 12 Months Year-on-year growth — revenue +8.5%, earnings -30.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.66% |
| 1 Year: | 8.50% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -30.67% |
Stock Price Performance
| 1 Year: | -8.15% |
| 6 Months: | -12.72% |
| 3 Months: | -12.17% |
| 1 Month: | -2.77% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)38.75 · Neutral
P/E of 30.62 is above the sector median of 25.65 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 13.7% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | IR Ingersoll Rand Inc. SPXR3K | 74.11 | 30.62 | $28.75B | 0.11% | 7.05% | 9.47% | 13.66% | - |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 144.75 | -131.59 | $1.10T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 704.05 | 30.31 | $323.63B | 0.80% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 293.54 | 34.53 | $304.57B | 0.60% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 194.71 | 34.34 | $262.42B | 1.51% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 827.42 | 23.73 | $220.37B | 0.22% | 6.30% | 82.58% | 8.68% | - |
| 7 | UNP Union Pacific Corporation SPXR3K | 298.09 | 24.16 | $177.09B | 2.01% | 15.22% | 39.70% | 2.30% | 7.77% |
| 8 | DE Deere & Company SPXR3K | 643.62 | 37.59 | $173.54B | 0.99% | 12.53% | 18.24% | 3.43% | 5.10% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 187.55 | 66.98 | $148.13B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 481.70M | 579.10M | 649.60M | 619.60M | 668.20M | 689.30M | 620.30M | 629.10M | 596.70M | 703.50M | 1.03B | 1.11B | 1.13B | 1.28B | 1.32B | 1.34B | 1.44B | 1.52B | 1.63B | 1.69B | 1.74B | 1.67B | 1.81B | 1.86B | 1.72B | 1.89B | 1.96B | 1.85B | 2.05B |
| Gross Profit | 171.50M | 164.20M | 174.60M | 215.90M | 253.90M | 231.90M | 249.30M | 262.40M | 230.50M | 234.40M | 221.50M | 217.70M | 308.60M | 430.00M | 452.10M | 512.70M | 514.30M | 526.10M | 569.80M | 575.30M | 664.20M | 697.50M | 739.30M | 746.30M | 793.30M | 815.00M | 765.50M | 824.90M | 855.20M | 792.40M | 862.60M |
| Operating Income | 26.00M | 20.20M | 36.80M | -101.60M | 96.00M | 89.80M | 101.40M | 117.70M | 80.20M | 74.60M | 72.90M | -76.10M | -45.00M | 69.00M | 121.30M | 140.10M | 163.90M | 157.00M | 197.40M | 190.00M | 240.30M | 272.40M | 318.40M | 293.20M | 271.80M | 356.30M | 302.50M | 76.40M | 375.50M | 289.70M | 380.30M |
| Net Income | -3.90M | -12.90M | -7.10M | -146.30M | 28.00M | 42.40M | 60.30M | 72.20M | 47.10M | 44.90M | 41.30M | -36.80M | -177.60M | 29.50M | -90.40M | 233.90M | 126.00M | 103.70M | 138.50M | 145.10M | 161.10M | 179.50M | 208.30M | 202.20M | 185.00M | 221.60M | 186.50M | -115.30M | 244.10M | 192.10M | 256.80M |
| Diluted EPS | -0.03 | -0.09 | -0.05 | -0.83 | 0.13 | 0.20 | 0.29 | 0.35 | 0.23 | 0.21 | 0.20 | -0.13 | -0.43 | 0.07 | -0.21 | 0.55 | 0.30 | 0.25 | 0.34 | 0.36 | 0.39 | 0.44 | 0.51 | 0.50 | 0.45 | 0.54 | 0.46 | -0.29 | 0.61 | 0.49 | 0.66 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.13B | 1.94B | 2.38B | 2.69B | 2.02B | 3.97B | 5.15B | 5.92B | 6.88B | 7.24B | 7.65B |
| Gross Profit | 779.10M | 716.70M | 897.90M | 1.01B | 778.30M | 1.40B | 1.99B | 2.33B | 2.88B | 3.17B | 3.34B |
| Operating Income | -205.40M | 103.50M | 109.10M | 443.00M | 194.10M | 59.60M | 565.70M | 817.30M | 1.16B | 1.30B | 1.14B |
| Net Income | -351.20M | -36.60M | 18.40M | 269.40M | 159.10M | -33.30M | 562.50M | 604.70M | 778.70M | 838.60M | 581.40M |
| Diluted EPS | -2.35 | -0.25 | 0.10 | 1.29 | 0.76 | -0.09 | 1.34 | 1.47 | 1.90 | 2.06 | 1.45 |
| R&D Expense | 26.00M | 22.00M | 26.00M | 24.00M | 22.00M | 58.00M | 74.00M | 91.30M | 108.20M | 116.60M | 114.30M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 4.46B | 4.32B | 4.62B | 4.49B | 4.63B | 16.06B | 15.15B | 14.77B | 15.56B | 18.01B | 18.30B |
| Total Equity | - | 405.50M | 265.90M | 1.48B | 1.68B | 1.87B | 9.12B | 9.00B | 9.20B | 9.78B | 10.18B | 10.09B |
| Cash & Equivalents | 184.20M | 228.30M | 255.80M | 393.30M | 221.20M | 505.50M | 1.75B | 2.11B | 1.61B | 1.60B | 1.54B | 1.25B |
| Long Term Debt | - | - | - | - | - | - | - | 2.78B | - | - | - | - |
| Total Liabilities | - | - | 4.04B | 3.14B | 2.81B | 2.76B | 6.87B | 6.08B | 5.51B | 5.72B | 7.76B | 8.14B |
| Current Liabilities | - | - | 497.90M | 561.80M | 596.40M | 574.60M | 1.50B | 1.47B | 1.67B | 1.83B | 1.82B | 2.07B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 172.10M | 165.60M | 200.50M | 444.50M | 343.30M | 914.30M | - | - | 1.38B | 1.40B | 1.36B |
| Investing Cash Flow | -84.00M | -82.10M | -60.80M | -235.00M | -54.30M | -37.90M | - | - | -1.06B | -3.11B | -660.60M |
| Financing Cash Flow | -35.00M | -43.00M | -17.40M | -373.00M | -11.50M | 328.70M | -1.16B | -954.00M | -337.50M | 1.71B | -1.05B |
| Share Buybacks | 2.10M | 14.10M | 3.60M | 40.70M | 18.60M | 2.10M | 736.80M | 261.10M | 263.00M | 260.70M | 1.02B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 36.6% | 37.0% | 37.8% | 37.6% | 38.6% | 35.4% | 38.6% | 39.3% | 41.9% | 43.8% | 43.6% |
| Operating Margin % | -9.7% | 5.3% | 4.6% | 16.5% | 9.6% | 1.5% | 11.0% | 13.8% | 16.9% | 18.0% | 15.0% |
| Net Margin % | -16.5% | -1.9% | 0.8% | 10.0% | 7.9% | -0.8% | 10.9% | 10.2% | 11.3% | 11.6% | 7.6% |
| ROE % | -86.6% | -13.8% | 1.2% | 16.1% | 8.5% | -0.4% | 6.2% | 6.6% | 8.0% | 8.2% | 5.8% |
| ROCE % | - | 2.7% | 2.7% | 11.4% | 4.8% | 0.4% | 4.1% | 6.2% | 8.5% | 8.0% | 7.1% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 7.81% | 30.30M | $2.39B |
| 2 | Capital World Investors | 7.20% | 27.93M | $2.20B |
| 3 | Price (T.Rowe) Associates Inc | 6.97% | 27.03M | $2.13B |
| 4 | Capital Research Global Investors | 6.50% | 25.22M | $1.99B |
| 5 | Vanguard Capital Management LLC | 6.31% | 24.48M | $1.93B |
| 6 | Vanguard Portfolio Management LLC | 4.34% | 16.86M | $1.33B |
| 7 | T. Rowe Price Investment Management, Inc. | 4.14% | 16.08M | $1.27B |
| 8 | State Street Corporation | 4.10% | 15.92M | $1.25B |
| 9 | Franklin Resources, Inc. | 3.98% | 15.44M | $1.22B |
| 10 | FMR, LLC | 3.42% | 13.28M | $1.05B |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IR
WEL OP EM CHF-S-AC (11437840.IR) Stock Forum & Discussion - Yahoo! Finance Canada
<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFBrbmp0UWJ1eE03WWxPMDJ2WTRCSGVQZHNaMURxQl9NRUNnYTkycWxSSEx3d0JRbjgxaU9aRVhDc3B4Y1pOS2I4aXBFMlBOQmpLRXdFZUxRZzBEOE8wUC1vXzBObF9RRmh6?oc=5" target="_blank">WEL OP EM CHF-S-AC (1143784…
Ingersoll Rand Inc. (IR) Stock Forecasts - Yahoo! Finance Canada
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQaXpXREV1WUozNkNFaUR4dlNvZkdKdmJmQ1hNay10N1NtazA2N2w0OTdyX2QyS2c1aEp6czZFbUpYbWt2ZFJoNVY5aG9fYjlyRkxXVGp2akU1OHJ1RllnQ2dTY1U4YzJucjVzLXFqT3Q4em1Ec05ra3JtS3Fub3Zrc091VEVPZUNUX2tEdz…
Ryanair Holdings plc (RYA.IR) stock price, news, quote and history - Yahoo Finance Australia
<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTFA2dC16YkQ2VEZRb19SYkxTTktXVTBhV1I2MGlwM0lHT2JJSEdhNXM0RTd4NUxTbThpV1lhZGptVFR3dVJIMVhmODRwWENxM0ZfckM0dw?oc=5" target="_blank">Ryanair Holdings plc (RYA.IR) stock price, news, quot…
FUNDLOGIC MS USD (24583770.IR) Stock Forum & Discussion - Yahoo! Finance Canada
<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE1jTXFNcW12RDAzdmZfYy1weGxPSHNGRHZ4c1VCYWo0UXFPbnlqZ01mcFBUaXp3ZW9qMm5vSUFVV0g4VFdYaERUQ3YyUU9VQWF0alhYUDVtQTY2bFdLRmlsZDdKTnJ1cVU2?oc=5" target="_blank">FUNDLOGIC MS USD (24583770.…
ODEY EUROP A/GBP (3778917.IR) Stock Forum & Discussion - Yahoo! Finance Canada
<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBJMURSMFpxMzJyZ2NPRnFZZ0pHN3hGanlURUJCcnBxbWhzNk85bjRRZ3I2TmZOSEVTUDZ0OW9NcVMtR2R3Y3NrelpMWjhsX2JlUDNsZDNYR0Z3YWZlV0U4S2JrdVpMOWM?oc=5" target="_blank">ODEY EUROP A/GBP (3778917.IR…
APS FAR ES USD-E-AC (13461261.IR) Stock Forum & Discussion - Yahoo Finance - Yahoo! Finance Canada
<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE43MTFDZjhYcXpVdDRyYkJyNmxVRGZSRVhfNDBlSjhFaTQ1UXFQcGR1dTNqdHRveXJWcXoycGFhR2tPSW1iZl9ScmNVcEwtM1F0cmNZY2JiLUZ1YkJtZ3lDTnFUT1gwWEpj?oc=5" target="_blank">APS FAR ES USD-E-AC (134612…
IR — Frequently Asked Questions
What is the current share price of Ingersoll Rand Inc. (IR)?
As of 2026-10-22 16:30 PDT, Ingersoll Rand Inc. (IR) trades at $74.11 on NYSE. Its 52-week range is $68.52 to $98.69.
What is the market capitalisation of IR?
Ingersoll Rand Inc. (IR) has a market capitalisation of $28.75B on NYSE.
What is the P/E ratio of IR?
IR trades at a trailing price-to-earnings (P/E) ratio of 30.62. The industry average P/E is 25.65. Its price-to-book (P/B) ratio is 2.74.
Does IR pay a dividend?
Ingersoll Rand Inc. (IR) currently offers a dividend yield of 0.11%.
What is the return on equity (ROE) of IR?
IR has a return on equity (ROE) of 9.47%. Its return on capital employed (ROCE) is 7.05%.
Is IR a good stock to buy?
This page provides a data-driven analysis of Ingersoll Rand Inc. (IR), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.